Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venglustat in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
CTR20190456Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of venglustat in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Sanofi. Started Mar 2019; status: terminated.
02
Drugs
venglustat
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on CTR20190456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190456.